Kohlberg Kravis Roberts yesterday delayed its New York listing, planned for this year, in one of the clearest indications of how the tide has turned against the private equity industry.

The US group, one of the pioneers of leveraged buy-outs with more than $60bn under management, said regulatory complications were mostly to blame for the postponement of its float until next year.